# Hyperpolarized Imaging for New Treatments

> **NCT04259970** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 64 (estimated)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** Initiation of CFTR Modulator

## Key facts

- **NCT ID:** NCT04259970
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-01-13
- **Primary completion:** 2026-05-01
- **Final completion:** 2026-12-31
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2026-01-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04259970

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04259970, "Hyperpolarized Imaging for New Treatments". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04259970. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*